Results 81 to 90 of about 13,238 (216)

Patient Diary Recorded Reactogenicity Following Dose 1 and Dose 2 of Vaccine Pooled Data.

open access: yes, 2016
Patient Diary Recorded Reactogenicity Following Dose 1 and Dose 2 of Vaccine Pooled Data.
Colin Gelder (3599288)   +8 more
core   +1 more source

Evaluating the reactogenicity of COVID-19 vaccines from network-meta analyses

open access: yesExpert Review of Vaccines, 2023
Background Evidence-based reassurances addressing vaccine-related concerns are crucial to promoting primary vaccination, completion of the primary series, and booster vaccination.
Giorgia Tiozzo   +6 more
doaj   +1 more source

Update on Selected Adverse Events of Concern Following Immunization With Acellular Pertussis Vaccines, a Narrative Review

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2370-2379, November 2026.
ABSTRACT Aim To provide an update paper on evidence of adverse events of concern following immunization (AEFI) with pertussis vaccines, focusing primarily on acellular (aP) vaccines. Methods Evidence was synthesised from epidemiological studies, systematic reviews over recent decades, expert interpretations in reviews from relevant research teams and ...
Lennart Nilsson, Jann Storsaeter
wiley   +1 more source

Summary of the Safety and Reactogenicity Results (all enrolled subjects, N = 120).

open access: yes, 2016
Summary of the Safety and Reactogenicity Results (all enrolled subjects, N = 120).
Richard Nichols (604329)   +15 more
core   +1 more source

Generalized Modules for Membrane Antigens (GMMA) Elicit Mild Local Reactogenicity After Intramuscular Injection in Absence of Aluminum Salt Adjuvant

open access: yesImmunity, Inflammation and Disease
Background and Objectives Generalized modules for membrane antigens (GMMA) are outer membrane vesicles derived from gram‐negative bacteria that can be used to design affordable subunit vaccines.
Raffaella Cecchi   +10 more
doaj   +1 more source

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Efficacy and safety data on quadrivalent influenza vaccines (QIVs) for immunization of Indian children are scarce. This phase 3, registration study evaluated the immunogenicity, safety, and tolerability of a QIV in Indian children aged 6–35 months (Group
Nijalingappa K. Kalappanavar   +11 more
doaj   +1 more source

The New Era of Respiratory Syncytial Virus Protection for Infants: A Mini Review of Current Tools for Immunoprophylaxis

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2466-2472, November 2026.
ABSTRACT Aim This mini review describes the history of infant respiratory syncytial virus (RSV) immunoprophylaxis and the latest advances in this area. It also reviews the efficacy, safety and impact of the recently introduced prophylactic strategies. Method This narrative review is based on a targeted review of published literature, with emphasis on ...
Santtu Heinonen, Pekka Vartiainen
wiley   +1 more source

Letter to the Editor: Biocompatibility and Reactogenicity of Materials: A Semantic and Logical Analysis of Definitions and Their Practical Significance [PDF]

open access: yes, 1996
Any biomaterial implanted into a living body elicits a distinct local reaction. This reaction depends on the physical, physico-chemical and chemical properties of the material.
Vetra, Janis J., Slutskii, Leonid I.
core   +1 more source

RESULTS OF A MULTICENTER CLINICAL STUDY OF A NEW COMBINATION VACCINE DTaP-HepB+Hib PRODUCTION OF THE CPA «MICROGEN» FOR IMMUNIZATION OF CHILDREN 6 MONTHS

open access: yesЖурнал микробиологии, эпидемиологии и иммунобиологии, 2018
Aim. The aim of the study is evaluate of reactogenicity, safety and immunogenicity of the native combined vaccine DTaP-HepB+Hib. Materials and methods. Assessment of reactogenicity, safety and immunogenicity of the drug is investigated in a multicenter ...
I. V. Feldblyum   +12 more
doaj   +1 more source

Exploring the Development of Vaccine Platforms, With a Particular Focus on the COVID‐19 Pandemic

open access: yesActa Paediatrica, Volume 115, Issue 11, Page 2421-2426, November 2026.
ABSTRACT Vaccines have been a cornerstone of human health for more than 200 years and one of the most important tools to reduce childhood deaths caused by pathogens. The concept of vaccines is basically to take something safe, make it immunogenic and induce an immune response in the host that will protect it against something dangerous. Live attenuated
Matti Sällberg
wiley   +1 more source

Home - About - Disclaimer - Privacy